BIIB - Biogen Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts25252827
Avg. Estimate3.754.0615.4416.31
Low estimate3.073.7615.0612.91
High estimate4.174.3716.1718.15
Year ago EPS5.254.7717.6715.44
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts25243130
Avg. Estimate2.38B2.37B9.61B9.35B
Low estimate2.32B2.25B9.41B8.61B
High estimate2.43B2.43B9.8B10.2B
Year ago sales2.59B2.51B10.17B9.61B
Sales growth (year/est)-8.20%-5.70%-5.60%-2.60%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS4.064.143.483.28
Actual EPS5.254.774.053.4
Difference1.190.630.570.12
Surprise %29.30%15.20%16.40%3.70%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate3.754.0615.4416.31
7 days ago3.754.0615.4416.31
30 days ago3.744.0615.4516.37
60 days ago3.994.2315.5316.51
90 days ago4.024.2415.5816.41
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A13
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBIIBIndustrySector(s)S&P 500
Current qtr.-28.60%N/AN/AN/A
Next qtr.-14.90%N/AN/AN/A
Current year-12.60%N/AN/AN/A
Next year5.60%N/AN/AN/A
Next 5 years (per annum)2.50%N/AN/AN/A
Past 5 years (per annum)-13.50%N/AN/AN/A